Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 347 (9012), 1367-1371
- https://doi.org/10.1016/s0140-6736(96)91011-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Clinical Sevoflurane Metabolism and DispositionAnesthesiology, 1995
- Clinical enflurane metabolism by cytochrome P450 2E1Clinical Pharmacology & Therapeutics, 1994
- Metabolism of the Chlorofluorocarbon Substitute 1,1-Dichloro-2,2,2-trifluoroethane by Rat and Human Liver Microsomes: The Role of Cytochrome P450 2E1Chemical Research in Toxicology, 1994
- Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and MethoxyfluraneAnesthesiology, 1993
- Single-dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1Clinical Pharmacology & Therapeutics, 1993
- HALOTHANE HEPATITISBritish Journal of Anaesthesia, 1991
- RISK FACTORS FOR HALOTHANE HEPATITISAnz Journal of Surgery, 1989
- Neoantigens Associated with Halothane HepatitisDrug Metabolism Reviews, 1989
- Influence of cimetidine and diethyldithiocarbamate on the metabolism of halothane and methoxyflurane in vitroPharmacological Research Communications, 1987
- Halothane hepatotoxicity in Fischer 344 rats pretreated with isoniazidToxicology and Applied Pharmacology, 1987